SIGA Technologies, Inc. (SIGA)
3.15
+0.04
(+1.29%)
USD |
NASDAQ |
Nov 04, 16:00
3.13
-0.02
(-0.63%)
Pre-Market: 09:22
SIGA Technologies Enterprise Value : 109.16M for Nov. 4, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2026 | 109.16M |
| November 03, 2026 | 106.29M |
| November 02, 2026 | 94.79M |
| October 30, 2026 | 101.26M |
| October 29, 2026 | 111.32M |
| October 28, 2026 | 120.66M |
| October 27, 2026 | 112.76M |
| October 26, 2026 | 109.52M |
| October 23, 2026 | 107.01M |
| October 22, 2026 | 109.16M |
| October 21, 2026 | 107.01M |
| October 20, 2026 | 109.16M |
| October 19, 2026 | 108.45M |
| October 16, 2026 | 110.60M |
| October 15, 2026 | 112.04M |
| October 14, 2026 | 105.57M |
| October 13, 2026 | 104.13M |
| October 12, 2026 | 109.88M |
| October 09, 2026 | 118.50M |
| October 08, 2026 | 118.50M |
| October 07, 2026 | 117.07M |
| October 06, 2026 | 119.22M |
| October 05, 2026 | 132.87M |
| October 02, 2026 | 125.69M |
| October 01, 2026 | 123.53M |
| Date | Value |
|---|---|
| September 30, 2026 | 127.12M |
| September 29, 2026 | 130.00M |
| September 28, 2026 | 131.44M |
| September 25, 2026 | 130.72M |
| September 24, 2026 | 116.35M |
| September 23, 2026 | 110.60M |
| September 22, 2026 | 117.07M |
| September 21, 2026 | 109.88M |
| September 18, 2026 | 108.45M |
| September 17, 2026 | 101.98M |
| September 16, 2026 | 105.57M |
| September 15, 2026 | 96.95M |
| September 14, 2026 | 109.16M |
| September 11, 2026 | 100.54M |
| September 10, 2026 | 99.82M |
| September 09, 2026 | 104.13M |
| September 08, 2026 | 112.76M |
| September 04, 2026 | 119.22M |
| September 03, 2026 | 114.91M |
| September 02, 2026 | 113.47M |
| September 01, 2026 | 115.63M |
| August 31, 2026 | 108.45M |
| August 28, 2026 | 102.70M |
| August 27, 2026 | 102.70M |
| August 26, 2026 | 103.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.881B |
| Corcept Therapeutics, Inc. | 8.302B |
| Veru, Inc. | 14.40M |
| Johnson & Johnson | 692.56B |
| Eli Lilly & Co. | 1.379T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 12.46M |
| Revenue (Quarterly) | 41.00M |
| Total Expenses (Quarterly) | 28.54M |
| EPS Diluted (Quarterly) | 0.1734 |
| Gross Profit Margin (Quarterly) | 57.17% |
| Profit Margin (Quarterly) | 30.40% |
| Earnings Yield | -1.25% |
| Normalized Earnings Yield | -1.257 |